UBS Downgrades Nutrien to Neutral, Lowers Price Target to $51
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has downgraded Nutrien (NYSE:NTR) from Buy to Neutral and reduced the price target from $66 to $51.
October 10, 2024 | 1:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
UBS analyst Joshua Spector downgraded Nutrien from Buy to Neutral and lowered the price target from $66 to $51, indicating a less optimistic outlook on the stock.
The downgrade from Buy to Neutral by UBS suggests a less favorable view on Nutrien's future performance. The significant reduction in the price target from $66 to $51 indicates potential downside risk, likely leading to negative short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100